Skip to main
APYX

APYX Stock Forecast & Price Target

APYX Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Apyx Medical is a growing company with a potential for significant market share in the expanding field of surgical aesthetics. Its products, such as Renuvion and AYON, offer cutting-edge technology that plastic surgeons and other physicians can use to achieve desired results for their patients. With a strong track record of financial growth and a strategic shift towards a more comprehensive platform approach, Apyx has the potential to continue its success and significantly increase its stock value.

Bears say

Apyx Medical is a relatively new company, having been founded in 1982. Although they offer innovative technologies in the cosmetic surgery market with their Renuvion platform and have expanded into international markets, market competition and negative financials could hinder the company's potential for growth and commercial success.

APYX has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Apyx Medical Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Apyx Medical Corp (APYX) Forecast

Analysts have given APYX a Strong Buy based on their latest research and market trends.

According to 5 analysts, APYX has a Strong Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $6.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $6.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Apyx Medical Corp (APYX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.